These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30268733)

  • 1. Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
    Teng Z; Sun S; Chen H; Huang J; Du P; Dong H; Xu X; Mu S; Zhang Z; Guo H
    Vaccine; 2018 Oct; 36(45):6752-6760. PubMed ID: 30268733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
    Terhuja M; Saravanan P; Tamilselvan RP
    Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
    Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
    Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
    Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
    J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P
    Virus Res; 2021 May; 297():198339. PubMed ID: 33596405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
    Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
    Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
    Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Jayeshbhai C; Hajam IA; Verma AK; Bhanuprakash V; Kondabattula G; Kishore S
    Vaccine; 2018 Aug; 36(35):5318-5324. PubMed ID: 30054161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-functional gold nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant.
    Teng Z; Sun S; Luo X; Zhang Z; Seo H; Xu X; Huang J; Dong H; Mu S; Du P; Zhang Z; Guo H
    Nanomedicine; 2021 Apr; 33():102358. PubMed ID: 33484882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
    Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
    Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice.
    Bai R; Li M; Tian Z; Hu Y; An M; Yuan W; Li L
    Vet Immunol Immunopathol; 2023 Oct; 264():110662. PubMed ID: 37862872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
    Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
    J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
    Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
    Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.